Insulin requirements, basal-bolus distribution and basal patterns used by type 1 diabetic patients (T1DM) starting insulin pump therapy (CSII) and after glucose control optimisation

被引：0

作者：

Saigi, I. ^{[1
]}

Tundidor, D. ^{[1
]}

Jordana, L. ^{[1
]}

Maria, M. A. ^{[1
]}

Corcoy, R. ^{[1
]}

Chico, A. ^{[1
]}

机构：

[1] Hosp Santa Creu & Sant Pau, Eduab HSP, Barcelona, Spain

来源：

DIABETOLOGIA | 2010年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1006

引用

页数：1

共 50 条

[31] Introduction of insulin glulisine in combination with insulin glargine to basal-bolus therapy improves metabolic control in patients with type 1 diabetes in everyday clinical practice
Ruhnau, Klaus-Juergen
DIABETES, 2006, 55 : A479 - A479
[32] Physician and Patient Perspectives after Switching Current Basal Insulin to Insulin Degludec in Type 1 Diabetes Mellitus (T1DM) Patients with Previous Hypoglycemia
Lecumberri, Edurne
Ortega, Maite
Antonio Quesada, Jose
Iturregui, Marta
Estrella, Alicia
Vazquez, Clotilde
Orozco-Beltran, Domingo
DIABETES, 2017, 66 : A620 - A620
[33] Reduced Mean Glucose and Glycemic Variability with Coadministration of Basal-Bolus Pramlintide and Insulin in Type 1 Diabetes (T1D)
Riddle, Matthew C.
Nahra, Rajaa
Han, Jenny
Hompesch, Marcus
Huffman, David
Strange, Poul
Ohman, Peter
DIABETES, 2017, 66 : A298 - A298
[34] The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
Klimontov, V. V.
Myakina, N. E.
DIABETES MELLITUS, 2015, 18 (04): : 66 - 71
[35] Efficacy and safety of 6-month treatment with insulin detemir in type 1 diabetic patients on a basal-bolus regimen
Roberts, A
Standl, E
Bayer, T
Munksgaard, E
Lang, H
DIABETOLOGIA, 2001, 44 : A207 - A207
[36] Effects of meal CHO content on insulin requirements in type 1 diabetic (Db1) subjects intensively treated with basal-bolus regimen
Chiasson, JL
Garon, J
Langelier, H
Poisson, D
Rabasa-Lhoret, R
DIABETES, 1998, 47 : A431 - A431
[37] FEAR OF HYPOGLYCAEMIA BETWEEN PEOPLE WITH TYPE 1 DIABETES ON INSULIN PUMP VERSUS BASAL BOLUS INSULIN THERAPY
Papazafiropoulou, A.
Kourtidou, F.
Tentolouris, N.
Antonopoulos, S.
DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A167 - A168
[38] Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy
Scheiner, G
Boyer, BA
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 69 (01) : 14 - 21
[39] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
K. Hermansen
P. Fontaine
K. K. Kukolja
V. Peterkova
G. Leth
M.-A. Gall
Diabetologia, 2004, 47 : 622 - 629
[40] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
Hermansen, K
Fontaine, P
Kukolja, KK
Peterkova, V
Leth, G
Gall, MA
DIABETOLOGIA, 2004, 47 (04) : 622 - 629

← 1 2 3 4 5 →